Vol. 26, Issue 5, 383-387, May 1998

Intestinal Absorption and Stability of Morphine 6-Glucuronide in Different Physiological Compartments of the Rat

F. Stain-Texier, P. Sandouk, and J-M. Scherrmann

INSERM, Unité 26 and Département de Pharmacocinétique de la Faculté de Pharmacie

Morphine 6-glucuronide (M6G) is an active metabolite of morphine that could be used as a drug, but its hydrolysis into morphine remains controversial. We investigated the acidic hydrolysis of M6G and found that the recovery of morphine did not exceed 5%. The stability of M6G was studied in different physiological compartments of male Sprague-Dawley rats. The formation of morphine after M6G incubation in feces was under 2% in the small intestine, whereas the formation of morphine in colon feces represented 85.6 ± 12.9% of the initial concentration of M6G. The stability of M6G was also determined ex vivo using the isolated perfused rat liver. The hepatic extraction ratio of M6G was very low (0.04 ± 0.02), but 88.7 ± 11.2% of the dose was excreted in bile. The elimination half-life of M6G in the perfusate (66.4 ± 20.6 min) was higher than the elimination half-life in bile (18.6 ± 2.5 min). The hydrolysis of M6G was low, with only 7.7% and 0.03% of morphine in the perfusate and bile, respectively. The perfusate level of morphine 3-glucuronide (M3G) resulting from morphine conjugation was 4.9 ± 3.6%. An in vivo experiment demonstrated that after oral administration, M6G was absorbed per se in the proximal intestine, and the process was prolonged over the 24-hr experiment due to its reabsorption following enterohepatic recirculation. Finally, 10.5 ± 4.3% of morphine and 12.9 ± 5.1% of M3G compared with M6G AUCs were found in plasma. These results show that M6G is weakly converted into morphine when orally absorbed, with a kinetic profile similar to a slow release formulation.